Articles dans des revues avec comité de lecture (192)
  1. 52. Baup, D., Fraga, L., Pernot, E., Van Acker, A., Vanherck, A. S., Breckpot, K., Thielemans, K. M., Schurmans, S., Moser, M., & Leo, O. (2009). Variegation and silencing in a lentiviral-based murine transgenic model. Transgenic research. doi:10.1007/s11248-009-9318-4
  2. 53. Eddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009). Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood, 113(11), 2426-2433. doi:10.1182/blood-2008-04-154682
  3. 54. Van Gool, F., Galli, M., Gueydan, C., Kruys, V., Prévot, P.-P., Bedalov, A., Mostoslavsky, R., Alt, F. W., De Smedt, T., & Leo, O. (2009). Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nature medicine, 15(2), 206-210. doi:10.1038/nm.1906
  4. 55. Van Gool, F., Galli, M., Rongvaux, A., Andris, F., & Leo, O. (2009). Métabolisme du NAD et contrôle de la réponse inflammatoire. MS. Médecine sciences, 25(6-7), 551-553.
  5. 56. Rongvaux, A., Galli, M., Denanglaire, S., Van Gool, F., Dreze, P. L., Szpirer, C., Bureau, F., Andris, F., & Leo, O. (2008). Nicotinamide phosphoribosyl transferase/pre-B cell colony-enhancing factor/visfatin is required for lymphocyte development and cellular resistance to genotoxic stress. The Journal of immunology, 181(7), 4685-4695.
  6. 57. Schwarz, T. F., & Leo, O. (2008). Immune response to human papillomavirus after prophylactic vaccination with AS04-adjuvanted HPV-16/18 vaccine: improving upon nature. Gynecologic oncology, 110(3 Suppl 1), S1-10. doi:10.1016/j.ygyno.2008.05.036
  7. 58. de Faudeur, G., De Trez, C., Muraille, E., & Leo, O. (2008). Normal development and function of dendritic cells in mice lacking IDO-1 expression. Immunology letters, 118(1), 21-29. doi:10.1016/j.imlet.2008.02.006
  8. 59. Mayer, A., Denanglaire, S., Viollet, B., Leo, O., & Andris, F. (2008). AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. European Journal of Immunology, 38(4), 948-956. doi:10.1002/eji.200738045
  9. 60. Busso, N., Karababa, M., Nobile, M., Rolaz, A., Van Gool, F., Galli, M., Leo, O., So, A., & De Smedt, T. (2008). Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD. PloS one, 3(5), e2267. doi:10.1371/journal.pone.0002267
  10. 61. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H., Sauvage, S., Matteotti, C., Van Acker, A. M., Leo, O., Figlewicz, D., Barro, M., Laoudj-Chenivesse, D., Belayew, A., Coppee, F., & Chen, Y.-W. (2007). DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proceedings of the National Academy of Sciences of the United States of America, 104(46), 18157-18162. doi:10.1073/pnas.0708659104
  11. 62. Marechal, Y., Pesesse, X., Jia, Y., Pouillon, V., Perez-Morga, D., Daniel, J., Izui, S., Cullen, P. J., Leo, O., Luo, H. R., Erneux, C., & Schurmans, S. (2007). Inositol 1,3,4,5-tetrakisphosphate controls proapoptotic Bim gene expression and survival in B cells. Proceedings of the National Academy of Sciences of the United States of America, 104(35), 13978-13983. doi:10.1073/pnas.0704312104
  12. 63. Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Matteotti, C., Arias, C., Corona, E. D., Nuñez, N. G., Leo, O., Wattiez, R., Figlewicz, D., Laoudj-Chenivesse, D., Belayew, A., Coppee, F., & Rosa, A. L. (2007). The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscular disorders, 17(8), 611-623. doi:10.1016/j.nmd.2007.04.002
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Suivant >>